Lista de obras - Simona Coco - Dominio Público Uruguay

Afatinib and Erlotinib in the treatment of squamous-cell lung cancer

artículo científico publicado en 2018

Afatinib for the treatment of advanced non-small-cell lung cancer.

artículo científico publicado en 2014

Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.

artículo científico publicado en 2014

Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma

artículo científico publicado en 2012

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer

artículo científico publicado en 2019

Belagenpumatucel-L for the treatment of non-small cell lung cancer

artículo científico

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

artículo científico publicado en 2014

Chromosomal aberrations and aneuploidy in oral potentially malignant lesions: distinctive features for tongue

artículo científico publicado en 2011

Chromosome 9q and 16q loss identified by genome-wide pooled-analysis are associated with tumor aggressiveness in patients with classic medulloblastoma.

artículo científico publicado en 2011

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.

artículo científico publicado en 2017

Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC): an (18)F-FDG PET/CT study

artículo científico

Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System

artículo científico publicado en 2014

Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

scientific article published on 01 October 2019

Dissecting the genomic complexity underlying medulloblastoma

artículo científico publicado en 2012

Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma.

artículo científico publicado en 2017

Efficacy of motesanib diphosphate in non-small-cell lung cancer

artículo científico publicado en 2014

Epigenetic Silencing of DKK3 in medulloblastoma.

artículo científico publicado en 2013

Exosomes: a new horizon in lung cancer.

artículo científico publicado en 2017

Familial neuroblastoma: a complex heritable disease.

artículo científico publicado en 2003

Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy

artículo científico publicado en 2016

Gene expression profiling identifies eleven DNA repair genes down-regulated during mouse neural crest cell migration

artículo científico publicado en 2011

Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells

artículo científico publicado en 2005

Genome and transcriptome analysis of neuroblastoma advanced diagnosis from innovative therapies.

artículo científico publicado en 2009

Genome instability model of metastatic neuroblastoma tumorigenesis by a dictionary learning algorithm.

artículo científico publicado en 2015

Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions.

artículo científico publicado en 2011

High genomic instability predicts survival in metastatic high-risk neuroblastoma

artículo científico publicado en 2012

Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization

artículo científico publicado en 2007

Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma.

artículo científico publicado en 2012

Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory

artículo científico publicado en 2008

Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab

scientific article published on 21 January 2019

Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer.

artículo científico publicado en 2019

Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer

artículo científico publicado en 2017

Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy.

artículo científico

Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.

artículo científico publicado en 2014

Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges

scientific article published on 19 December 2019

Loss of 10q26.1-q26.3 in association with 7q34-q36.3 gain or 17q24.3-q25.3 gain predict poor outcome in pediatric medulloblastoma.

artículo científico publicado en 2011

Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds

scientific article published on 07 June 2019

Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform

artículo científico publicado en 2015

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer

scientific article published in 2021

Oral vinorelbine in the treatment of non-small-cell lung cancer.

artículo científico

Pemetrexed for the treatment of non-small cell lung cancer.

artículo científico publicado en 2013

Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.

artículo científico publicado en 2016

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient

scientific article published on 30 April 2020

Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab

scientific article published on 10 July 2019

Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma.

artículo científico publicado en 2016

Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer.

artículo científico publicado en 2014

Reply to the Letter to the Editor by C. Nicolazzo et al.: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".

artículo científico publicado en 2017

Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment

scientific article published on 11 February 2020

Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.

artículo científico publicado en 2011

Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.

artículo científico

Role of microRNAs in malignant mesothelioma.

artículo científico

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.

artículo científico publicado en 2015

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study

scientific article published on 20 July 2019

Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients

artículo científico publicado en 2019

Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer

artículo científico publicado en 2022

The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer

article

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients

artículo científico publicado en 2019

Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma

artículo científico publicado en 2009

Transcribed-ultra conserved region expression profiling from low-input total RNA

artículo científico publicado en 2010

Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma.

artículo científico publicado en 2015

Understanding the checkpoint blockade in lung cancer immunotherapy

artículo científico publicado en 2017

Vinflunine for the treatment of non-small cell lung cancer.

artículo científico publicado en 2016

Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report

artículo científico publicado en 2016

Lista de obras de Simona Coco

Afatinib and Erlotinib in the treatment of squamous-cell lung cancer

Afatinib for the treatment of advanced non-small-cell lung cancer.

Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.

Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer

Belagenpumatucel-L for the treatment of non-small cell lung cancer

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

Chromosomal aberrations and aneuploidy in oral potentially malignant lesions: distinctive features for tongue

Chromosome 9q and 16q loss identified by genome-wide pooled-analysis are associated with tumor aggressiveness in patients with classic medulloblastoma.

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.

Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC): an (18)F-FDG PET/CT study

Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System

Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

Dissecting the genomic complexity underlying medulloblastoma

Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma.

Efficacy of motesanib diphosphate in non-small-cell lung cancer

Epigenetic Silencing of DKK3 in medulloblastoma.

Exosomes: a new horizon in lung cancer.

Familial neuroblastoma: a complex heritable disease.

Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy

Gene expression profiling identifies eleven DNA repair genes down-regulated during mouse neural crest cell migration

Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells

Genome and transcriptome analysis of neuroblastoma advanced diagnosis from innovative therapies.

Genome instability model of metastatic neuroblastoma tumorigenesis by a dictionary learning algorithm.

Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions.

High genomic instability predicts survival in metastatic high-risk neuroblastoma

Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization

Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma.

Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory

Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab

Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer.

Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer

Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy.

Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.

Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges

Loss of 10q26.1-q26.3 in association with 7q34-q36.3 gain or 17q24.3-q25.3 gain predict poor outcome in pediatric medulloblastoma.

Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds

Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer

Oral vinorelbine in the treatment of non-small-cell lung cancer.

Pemetrexed for the treatment of non-small cell lung cancer.

Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient

Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab

Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma.

Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer.

Reply to the Letter to the Editor by C. Nicolazzo et al.: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".

Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment

Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.

Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.

Role of microRNAs in malignant mesothelioma.

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study

Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients

Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer

The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients

Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma

Transcribed-ultra conserved region expression profiling from low-input total RNA

Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma.

Understanding the checkpoint blockade in lung cancer immunotherapy

Vinflunine for the treatment of non-small cell lung cancer.

Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report